- Home
- SOL vs VTGN Comparison
SOL vs VTGN Comparison
Compare SOL & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOL
- VTGN
- Stock Information
- Founded
- SOL 2005
- VTGN 1998
- Country
- SOL United States
- VTGN United States
- Employees
- SOL N/A
- VTGN N/A
- Industry
- SOL Semiconductors
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- SOL Technology
- VTGN Health Care
- Exchange
- SOL Nasdaq
- VTGN Nasdaq
- Market Cap
- SOL 89.7M
- VTGN 82.7M
- IPO Year
- SOL 2008
- VTGN N/A
- Fundamental
- Price
- SOL $1.66
- VTGN $2.93
- Analyst Decision
- SOL Buy
- VTGN
- Analyst Count
- SOL 3
- VTGN 0
- Target Price
- SOL $3.83
- VTGN N/A
- AVG Volume (30 Days)
- SOL 181.6K
- VTGN 179.0K
- Earning Date
- SOL 03-27-2025
- VTGN 02-13-2025
- Dividend Yield
- SOL N/A
- VTGN N/A
- EPS Growth
- SOL N/A
- VTGN N/A
- EPS
- SOL N/A
- VTGN N/A
- Revenue
- SOL $102,489,000.00
- VTGN $698,000.00
- Revenue This Year
- SOL N/A
- VTGN N/A
- Revenue Next Year
- SOL $47.66
- VTGN N/A
- P/E Ratio
- SOL N/A
- VTGN N/A
- Revenue Growth
- SOL 25.98
- VTGN N/A
- 52 Week Low
- SOL $1.41
- VTGN $2.22
- 52 Week High
- SOL $3.00
- VTGN $5.74
- Technical
- Relative Strength Index (RSI)
- SOL 36.27
- VTGN 53.66
- Support Level
- SOL $1.67
- VTGN $2.72
- Resistance Level
- SOL $1.79
- VTGN $3.10
- Average True Range (ATR)
- SOL 0.08
- VTGN 0.19
- MACD
- SOL -0.00
- VTGN 0.00
- Stochastic Oscillator
- SOL 18.52
- VTGN 66.00
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.